What are the major opportunities in the Anaphylaxis market? What are the strategies for the Anaphylaxis market?

For detailed insights on the major opportunities and strategies in the Anaphylaxis market, Read More

How does the Anaphylaxis market relate to the overall economy and other similar markets?

For detailed insights on the key dynamics influencing the Anaphylaxis market growth and SWOT analysis of the Anaphylaxis industry, Read More

For detailed insights on Anaphylaxis's relation to the overall economy and other similar markets,

What are the latest mergers and acquisitions in the Anaphylaxis industry? Read More

For detailed insights on the mergers and acquisitions in the Anaphylaxis industry,

What are the key dynamics influencing the Anaphylaxis market growth? SWOT analysis of the Anaphylaxis market. Read More

Item added to cart!

Published : December 2025

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00 $3367.00

Purchase This Report Download Sample PDF

Purchase This Report

Anaphylaxis Global Market Report 2025

Name: Anaphylaxis Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Drug Class (Epinephrine, Steroids, Antihistamines, Beta-antagonists, Other Drug Class), By Route Of Administration (Parenteral, Oral, Other Routes Of Administration), By Application (Food Allergy, Pollen Allergy, Dust Mites Allergy, Other Applications) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Anaphylaxis Market Overview

• Anaphylaxis market size has reached to $3.24 billion in 2024

• Expected to grow to $4.78 billion in 2029 at a compound annual growth rate (CAGR) of 8.1%

• Growth Driver: Impact of Rising Food Allergies on the Growth Of The Market

• Market Trend: Product Innovations Driving Advancements In The Treatment

• North America was the largest region in 2024.

What Is Covered Under Anaphylaxis Market?

Anaphylaxis is a severe, life-threatening allergic reaction that occurs rapidly, often resulting in difficulty breathing, swelling, and a drop in blood pressure, requiring immediate medical intervention. Management of anaphylaxis involves prompt administration of epinephrine, followed by monitoring in a healthcare setting to stabilize the patient and prevent further complications.

The main drug classes in anaphylaxis are epinephrine, steroids, antihistamines, beta-antagonists, and others. Epinephrine is a life-saving medication used to rapidly reverse severe allergic reactions, such as anaphylaxis, by constricting blood vessels, relaxing airway muscles, and increasing heart rate. These are administered by routes including parenteral, oral, and others for the applications such as food allergy, pollen allergy, dust mite’s allergy, and others.

Anaphylaxis Market Size and growth rate 2025 to 2029: Graph

What Is The Anaphylaxis Market Size 2025 And Growth Rate?

What Is The Anaphylaxis Market Growth Forecast?

The anaphylaxis market size is expected to see strong growth in the next few years. It will grow to $4.78 billion in 2029 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to increasing urbanization and lifestyle changes, a growing incidence of anaphylaxis cases, rising disposable incomes in emerging markets, government funding for allergy research, and innovations in delivery systems for emergency treatment. Major trends in the forecast period include growing demand for injectable auto-injectors, integration of digital health solutions in anaphylaxis management, increased focus on product affordability, rise in preventative treatments and vaccines, increased use of biologics for allergy treatment.

The forecast of 8.1% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. emergency medicine by increasing costs for epinephrine auto-injectors and intravenous (IV) antihistamines imported from UK and Switzerland, potentially compromising rapid response capabilities and raising Emergency Room(ER) medication expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Anaphylaxis Market Segmented?

1) By Drug Class: Epinephrine, Steroids, Antihistamines, Beta-antagonists, Other Drug Class

2) By Route Of Administration: Parenteral, Oral, Other Routes Of Administration

3) By Application: Food Allergy, Pollen Allergy, Dust Mites Allergy, Other Applications

Subsegments:

1) By Epinephrine: Auto-injectors, Prefilled Syringes, Vials

2) By Steroids: corticosteroids, Glucocorticoids, Mineralocorticoids

3) By Antihistamines: H1-receptor Antagonists, H2-receptor Antagonists

4) By Beta-antagonists: Selective Beta-blockers, Non-selective Beta-blockers

5) By Other Drug Class: Leukotriene Receptor Antagonists, Mast Cell Stabilizers

What Is Driving The Anaphylaxis Market? Impact of Rising Food Allergies on the Growth Of The Market

The rising prevalence of food allergies is expected to propel the growth of the anaphylaxis market going forward. Food allergies are immune system reactions triggered by certain foods, causing symptoms that range from mild to severe, including life-threatening anaphylaxis. The rising prevalence of food allergies are due to factors such as changing dietary habits, environmental influences, and improved awareness and diagnosis. Anaphylaxis treatment provides critical, life-saving intervention for food allergy patients by rapidly reversing severe allergic reactions, reducing symptoms such as swelling, difficulty breathing, and drop in blood pressure, ensuring immediate stabilization and preventing potentially fatal outcomes, while empowering patients with the tools for timely action in future allergic incidents. For instance, in September 2024, according to the World Health Organization (WHO), a Switzerland-based United Nations (UN) organization, around 220 million people globally are affected by food allergies. A single food product can include multiple allergens, and individuals may be allergic to more than one type of food. Additionally, in May 2024, according to the Patterns and Prevalence of Adult Food Allergy (PAFA) report published by the Food Standards Agency (FSA), a UK-based non-ministerial department, over 30% of adults reported food-related adverse reactions, and clinical assessments confirmed food allergies in approximately 6% of UK adults, equating to around 2.4 million people. Therefore, the rising prevalence of food allergies is driving the growth of the anaphylaxis industry.

Who Are The Major Players In The Global Anaphylaxis Market?

Major companies operating in the anaphylaxis market are Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi SA, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline Plc, F. Hoffman-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Bausch Health Companies Inc., Perrigo Company plc, Dr Reddy’s Laboratories Ltd., Cipla Ltd., Amneal Pharmaceuticals Inc., Mylan N.V., ALK-Abelló, Stallergenes Greer, Allergy Therapeutics

What Are The Key Trends Of The Global Anaphylaxis Market? Product Innovations Driving Advancements In The Treatment

Major companies operating in the anaphylaxis market are focusing on developing advanced epinephrine nasal spray, which enable faster, more efficient drug delivery during emergencies. Epinephrine nasal spray is a medical device that delivers epinephrine (adrenaline) through the nasal passages as a treatment for severe allergic reactions, including anaphylaxis. For instance, in August 2024, ARS Pharmaceuticals, a US-based biotechnology company, announced Neffy (epinephrine nasal spray) approved by the Food and Drug Administration, a US-based government agency, marking it as the first and only needle-free treatment for type I allergic reactions, including anaphylaxis. This innovative nasal spray provides a non-invasive alternative to traditional epinephrine autoinjectors, offering a potentially more accessible option for emergency treatment. Neffy aims to improve patient compliance by eliminating the need for needles while delivering rapid, life-saving epinephrine during severe allergic reactions.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Anaphylaxis Market? Nestlé Health Science Partners With Anaphylaxis UK To Raise Allergy Awareness And Enhance Safety Confidence

In October 2023, Nestlé Health Science SA, a Switzerland-based nutritional science company that offers anaphylaxis, announced a partnership with Anaphylaxis UK, to supporting individuals with severe allergies. This collaboration aims to raise awareness about the serious consequences of anaphylaxis and empower people to manage allergies safely through education and resources. Anaphylaxis UK is a UK-based severe allergies charity.

What Is The Regional Outlook For The Global Anaphylaxis Market?

North America was the largest region in the anaphylaxis market in 2024. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Anaphylaxis Market?

The anaphylaxis market consists of syringes and vials, intravenous (IV) epinephrine, diagnostic kits, and monitoring devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Anaphylaxis Industry?

The anaphylaxis market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the anaphylaxis industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Anaphylaxis Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$3.5 billion
Revenue Forecast In 2034	$4.78 billion
Growth Rate	CAGR of 8.1% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	The anaphylaxis market covered in this report is segmented – 1) By Drug Class: Epinephrine, Steroids, Antihistamines, Beta-antagonists, Other Drug Class 2) By Route Of Administration: Parenteral, Oral, Other Routes Of Administration 3) By Application: Food Allergy, Pollen Allergy, Dust Mites Allergy, Other Applications Subsegments: 1) By Epinephrine: Auto-injectors, Prefilled Syringes, Vials 2) By Steroids: Corticosteroids, Glucocorticoids, Mineralocorticoids 3) By Antihistamines: H1-receptor Antagonists, H2-receptor Antagonists 4) By Beta-antagonists: Selective Beta-blockers, Non-selective Beta-blockers 5) By Other Drug Class: Leukotriene Receptor Antagonists, Mast Cell Stabilizers
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi SA, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline Plc, F. Hoffman-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Bausch Health Companies Inc., Perrigo Company plc, Dr Reddy’s Laboratories Ltd., Cipla Ltd., Amneal Pharmaceuticals Inc., Mylan N.V., ALK-Abelló, Stallergenes Greer, Allergy Therapeutics
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Anaphylaxis Market Characteristics

3. Anaphylaxis Market Trends And Strategies

4. Anaphylaxis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Anaphylaxis Growth Analysis And Strategic Analysis Framework

5.1. Global Anaphylaxis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Anaphylaxis Market Growth Rate Analysis

5.4. Global Anaphylaxis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Anaphylaxis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Anaphylaxis Total Addressable Market (TAM)

6. Anaphylaxis Market Segmentation

6.1. Global Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Epinephrine

Steroids

Antihistamines

Beta-antagonists

Other Drug Class

6.2. Global Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Parenteral

Oral

Other Routes Of Administration

6.3. Global Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Food Allergy

Pollen Allergy

Dust Mites Allergy

Other Applications

6.4. Global Anaphylaxis Market, Sub-Segmentation Of Epinephrine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Auto-injectors

Prefilled Syringes

Vials

6.5. Global Anaphylaxis Market, Sub-Segmentation Of Steroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Corticosteroids

Glucocorticoids

Mineralocorticoids

6.6. Global Anaphylaxis Market, Sub-Segmentation Of Antihistamines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

H1-receptor Antagonists

H2-receptor Antagonists

6.7. Global Anaphylaxis Market, Sub-Segmentation Of Beta-antagonists, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Selective Beta-blockers

Non-selective Beta-blockers

6.8. Global Anaphylaxis Market, Sub-Segmentation Of Other Drug Class, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Leukotriene Receptor Antagonists

Mast Cell Stabilizers

7. Anaphylaxis Market Regional And Country Analysis

7.1. Global Anaphylaxis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Anaphylaxis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Anaphylaxis Market

8.1. Asia-Pacific Anaphylaxis Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Anaphylaxis Market

9.1. China Anaphylaxis Market Overview

9.2. China Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Anaphylaxis Market

10.1. India Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Anaphylaxis Market

11.1. Japan Anaphylaxis Market Overview

11.2. Japan Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Anaphylaxis Market

12.1. Australia Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Anaphylaxis Market

13.1. Indonesia Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Anaphylaxis Market

14.1. South Korea Anaphylaxis Market Overview

14.2. South Korea Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Anaphylaxis Market

15.1. Western Europe Anaphylaxis Market Overview

15.2. Western Europe Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Anaphylaxis Market

16.1. UK Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Anaphylaxis Market

17.1. Germany Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Anaphylaxis Market

18.1. France Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Anaphylaxis Market

19.1. Italy Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Anaphylaxis Market

20.1. Spain Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Anaphylaxis Market

21.1. Eastern Europe Anaphylaxis Market Overview

21.2. Eastern Europe Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Anaphylaxis Market

22.1. Russia Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Anaphylaxis Market

23.1. North America Anaphylaxis Market Overview

23.2. North America Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Anaphylaxis Market

24.1. USA Anaphylaxis Market Overview

24.2. USA Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Anaphylaxis Market

25.1. Canada Anaphylaxis Market Overview

25.2. Canada Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Anaphylaxis Market

26.1. South America Anaphylaxis Market Overview

26.2. South America Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Anaphylaxis Market

27.1. Brazil Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Anaphylaxis Market

28.1. Middle East Anaphylaxis Market Overview

28.2. Middle East Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Anaphylaxis Market

29.1. Africa Anaphylaxis Market Overview

29.2. Africa Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Anaphylaxis Market Competitive Landscape And Company Profiles

30.1. Anaphylaxis Market Competitive Landscape

30.2. Anaphylaxis Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

31. Anaphylaxis Market Other Major And Innovative Companies

31.1. Sanofi SA

31.2. AstraZeneca plc

31.3. Abbott Laboratories

31.4. GlaxoSmithKline Plc

31.5. F. Hoffman-La Roche Ltd.

31.6. Teva Pharmaceutical Industries Ltd.

31.7. Bausch Health Companies Inc.

31.8. Perrigo Company plc

31.9. Dr Reddy’s Laboratories Ltd.

31.10. Cipla Ltd.

31.11. Amneal Pharmaceuticals Inc.

31.12. Mylan N.V.

31.13. ALK-Abelló

31.14. Stallergenes Greer

31.15. Allergy Therapeutics

32. Global Anaphylaxis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Anaphylaxis Market

34. Recent Developments In The Anaphylaxis Market

35. Anaphylaxis Market High Potential Countries, Segments and Strategies

35.1 Anaphylaxis Market In 2029 - Countries Offering Most New Opportunities

35.2 Anaphylaxis Market In 2029 - Segments Offering Most New Opportunities

35.3 Anaphylaxis Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Anaphylaxis Market, Sub-Segmentation Of Epinephrine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Anaphylaxis Market, Sub-Segmentation Of Steroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Anaphylaxis Market, Sub-Segmentation Of Antihistamines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Anaphylaxis Market, Sub-Segmentation Of Beta-antagonists, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Anaphylaxis Market, Sub-Segmentation Of Other Drug Class, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Anaphylaxis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Global Anaphylaxis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: Asia-Pacific, Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: China, Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: India, Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Japan, Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Australia, Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: Indonesia, Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: South Korea, Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: Western Europe, Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: UK, Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: Germany, Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: France, Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Italy, Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Spain, Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Eastern Europe, Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Russia, Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: North America, Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: USA, Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: Canada, Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: South America, Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Brazil, Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Middle East, Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Africa, Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 79: Pfizer Inc. Financial Performance

Table 80: Johnson & Johnson Services Inc. Financial Performance

Table 81: Merck & Co. Inc. Financial Performance

Table 82: Bayer AG Financial Performance

Table 83: Novartis AG Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Anaphylaxis Market, Sub-Segmentation Of Epinephrine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Anaphylaxis Market, Sub-Segmentation Of Steroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Anaphylaxis Market, Sub-Segmentation Of Antihistamines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Anaphylaxis Market, Sub-Segmentation Of Beta-antagonists, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Anaphylaxis Market, Sub-Segmentation Of Other Drug Class, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Anaphylaxis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Global Anaphylaxis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: Asia-Pacific, Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: China, Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: India, Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Japan, Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Australia, Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: Indonesia, Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: South Korea, Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: Western Europe, Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: UK, Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: Germany, Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: France, Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Italy, Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Spain, Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Eastern Europe, Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Russia, Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: North America, Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: USA, Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: Canada, Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: South America, Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Brazil, Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Middle East, Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Anaphylaxis Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Anaphylaxis Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Africa, Anaphylaxis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 79: Pfizer Inc. Financial Performance

Figure 80: Johnson & Johnson Services Inc. Financial Performance

Figure 81: Merck & Co. Inc. Financial Performance

Figure 82: Bayer AG Financial Performance

Figure 83: Novartis AG Financial Performance

Strategic Growth Drivers Shaping the CRISPR And Cas Gene Market Outlook 2025- 2034:Personalized Therapy Driving Surge In CRISPR And Cas Gene Market Growth

Emerging Growth Drivers in the Crohn's Disease (CD) Treatment Market Landscape: Increasing Prevalence Of Inflammatory Bowel Diseases Fuels Growth In The Crohn’S Disease Treatment Market

Cryochambers Market Outlook 2025–2034: Identifying Growth Drivers, Technology Trends, and Policy Impact

Cryotherapy Market Insights: In-Depth Look at Growth Trends, Market Size, and Opportunities for 2025-2034

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Organic Feed Global Market Report 2025 – By Type (Cereals and Grains, Oilseeds, Other Types), By Additives (Amino Acids, Vitamins, Minerals, Acidifiers, Antioxidants, Pre & Probiotics, Flavors and Sweeteners, Other Addit...

Bioprocess Bags Global Market Report 2025 – By Type (2D Bioprocess Bags, 3D Bioprocess Bags, Other Bags And Accessories), By Workflow (Upstream Process, Downstream Process, Process Development), By Capacity (Small, Mediu...

Respiratory Diseases Drugs Global Market Report 2022 – By Type (Anti-Asthmatics And COPD Drugs, Cough And Cold Preparations), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores), By Route Of Adm...

Medical Device Reprocessing Global Market Report 2025 – By Type (Reprocessing support and Services, Reprocessing Medical Devices), By Device Category (Critical Devices, Semi-Critical Devices, Non-Critical Devices), By Ap...

Full Service Restaurants Global Market Report 2025 – By Service (Casual Dining Restaurants, Fine Dining Restaurants), By Model (Independent Consumer Foodservice, Chained Consumer Foodservice), By Location (Standalone, Re...

Application Testing Services Global Market Report 2025 – By Testing Type (Functionality Testing, Usability Testing, Performance Testing, Compatibility Testing, Security Testing, Compliance Testing, Automation Testing, Ot...

All Wheel Drive Global Market Report 2025 – By Type (Automatic All-Wheel Drive (AWD), Manual All-Wheel Drive (AWD)), By Component (Differential, Transfer Case, Propeller Shaft, Power Transfer Unit, Final Drive Unit), By ...

Frequently Asked Questions

What is the definition of the Anaphylaxis market?

How will the Anaphylaxis market drivers and restraints affect the market dynamics? What forces will shape the Anaphylaxis industry going forward?

The market major growth driver - Impact of Rising Food Allergies on the Growth Of The Market. For further insights on this market, request a sample here

What is the forecast market size or the forecast market value of the Anaphylaxis market?

The anaphylaxis market size has grown strongly in recent years. It will grow from $3.24 billion in 2024 to $3.5 billion in 2025 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to the rising prevalence of food allergies, increased awareness of anaphylaxis, growing healthcare infrastructure, better diagnosis and management, and increasing availability of epinephrine auto-injectors. The anaphylaxis market size is expected to see strong growth in the next few years. It will grow to " $4.78 billion in 2029 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to increasing urbanization and lifestyle changes, a growing incidence of anaphylaxis cases, rising disposable incomes in emerging markets, government funding for allergy research, and innovations in delivery systems for emergency treatment. Major trends in the forecast period include growing demand for injectable auto-injectors, integration of digital health solutions in anaphylaxis management, increased focus on product affordability, rise in preventative treatments and vaccines, increased use of biologics for allergy treatment. For further insights on this market, request a sample here

How is the Anaphylaxis market segmented?

The anaphylaxismarket covered in this report is segmented –
1) By Drug Class: Epinephrine; Steroids; Antihistamines; Beta-antagonists; Other Drug Class
2) By Route Of Administration: Parenteral; Oral; Other Routes Of Administration
3) By Application: Food Allergy; Pollen Allergy; Dust Mites Allergy; Other Applications Subsegments:
1) By Epinephrine: Auto-injectors; Prefilled Syringes; Vials
2) By Steroids: Corticosteroids; Glucocorticoids; Mineralocorticoids
3) By Antihistamines: H1-receptor Antagonists; H2-receptor Antagonists
4) By Beta-antagonists: Selective Beta-blockers; Non-selective Beta-blockers
5) By Other Drug Class: Leukotriene Receptor Antagonists; Mast Cell Stabilizers For further insights on this market, request a sample here

Which region has the largest share of the Anaphylaxis market? What are the other regions covered in the report?

North America was the largest region in the anaphylaxis market in 2024. The regions covered in the anaphylaxis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Who are the major players in the Anaphylaxis market?

What are the key trends in the Anaphylaxis market?

Major trends in this market include Product Innovations Driving Advancements In The Treatment. For further insights on this market, request a sample here.